Combined agonist adjuvant for coronavirus vaccine
US-2024252620-A1 · Aug 1, 2024 · US
This page is not indexed by search engines while we improve data quality.
Ichan School Of Medicine At Mount Sinai patents
Ichan School Of Medicine At Mount Sinai holds 4 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 4 |
| Recent patents | 1 |
| First publication | Sep 6, 2018 |
| Latest publication | Aug 1, 2024 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents
US-10759790-B2 · Sep 1, 2020 · US
Compositions and methods for treating cancer
US-10744141-B2 · Aug 18, 2020 · US
Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents
US-2018251456-A1 · Sep 6, 2018 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Combined agonist adjuvant for coronavirus vaccine
US-2024252620-A1 · Aug 1, 2024 · US
Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents
US-10759790-B2 · Sep 1, 2020 · US
Compositions and methods for treating cancer
US-10744141-B2 · Aug 18, 2020 · US
Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents
US-2018251456-A1 · Sep 6, 2018 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 4 |
| Chemistry & Metallurgy | 3 |